Immune Reconstitution Following Allogeneic Peripheral Blood Progenitor Cell Transplantation

References

• Bone Marrow Transplantation. Parkman R. Immunological reconstitution following bone marrow transplantation, S. J. Farman, K. G. Blume, D. E. Thomas. Blackwell Scientific Publications, Boston MAUSA 1994; 504–512
   Google Scholar
• Storek J., Witherspoon R. P., Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413–425
   PubMed Web of Science ®Google Scholar
• Small T., Keever C., Weiner‐Fedus S. B‐cell differentiation following autologous, conventional, or T‐cell depleted bone marrow transplantation: a recapitulation of normal B‐cell ontogeny. Blood 1990; 76: 1647–1656
   PubMed Web of Science ®Google Scholar
• De Gast G. C., Verdonck L. F., Middeldorp J. M. Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood 1985; 66: 428–431
   PubMed Web of Science ®Google Scholar
• Mackall C., Granger L., Sheard M., Cepeda R., Gress R. T‐cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic‐derived versus thymic‐independent progeny. Blood 1993; 82: 2585–2594
   PubMed Web of Science ®Google Scholar
• Henon P. R., Liang H., Beck‐Wirth G., Eisenmann J. C., Lepers M., Wunder E., Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 12: 285–291
   Google Scholar
• Roberts M. M., To L. B., Gillis D., Mundy J., Rawling C., Ng K., Juttner C. A. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469–475
   PubMed Web of Science ®Google Scholar
• Talmadge J. E., Reed E., Ino K., Kenssinger A., Kuszynski C., Heimann D., Varney M., Jackson J., Vose J. M., Bierman P. J. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161–172
   PubMed Web of Science ®Google Scholar
• Tjonnfjord G. E., Steen R., Evensen S. A., Thorsby E., Egeland T. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony‐stimulating factor. Blood 1994; 84: 2795–2801
   PubMed Web of Science ®Google Scholar
• Dreger P., Haferlach T., Eckstein V., Jacobs S., Suttorp M., Loffler H., Muller‐Rucholtz W., Schmitz N. G‐CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609–613
   PubMed Web of Science ®Google Scholar
• Martínez C., Urbano‐Ispizua A., Rozman C., Marín P., Mazzara R., Cameras E., Rovira M., Sierra J., Briones J., Ordinas A., Montserrat E. Effects of G‐CSF administration and peripheral blood progenitor cells collections in 20 healthy donors. Ann of Hematol 1996; 72: 269–272
   PubMed Web of Science ®Google Scholar
• Kusnierz‐Glaz C. R., Still B. J., Amano M., Zukor J. D., Negrin R. S., Blume K. G., Strober S. Granulocyte colony‐stimulating factor‐induced comobilization of CD4+CD8+ T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors. Blood 1997; 89: 2586–2595
   PubMed Web of Science ®Google Scholar
• Pan L., Delmonte J., Jalonen C. K., Ferrara J. L. Pretreatment of donor mice with granulocyte colony‐stimulating factor polarizes donor T‐lymphocytes toward type‐2 cytokine production and reduces seventy of experimental graft‐versus‐host disease. Blood 1995; 86: 4422–4429
   PubMed Web of Science ®Google Scholar
• Krenger W., Snyder K. M., Byon J. H. C. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft‐versus‐host disease. J Immunol 1995; 155: 585–593
   PubMed Web of Science ®Google Scholar
• Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209–226
   PubMed Web of Science ®Google Scholar
• Martinez C., Urbano‐Ispizua A., Rozman C., Marin P., Rovira M., Sierra J., Montfort N., Carreras E., Montserrat E. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unrnanipulated grafts. Experimental Hematology 1999; 27: 561–568
   PubMed Web of Science ®Google Scholar
• Pavletic Z. S., Joshi S. S., Pirmccello S. J., Tarantolo S. R., Kollath J., Reed E. C., Bierman P. J., Vose J. M., Wakentin P. I., Gross T. G., Nasrati K., Armitage J. O., Kessinger A., Bishop M. R. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33–41
   PubMed Web of Science ®Google Scholar
• Keever C., Small T., Flomenberg N., Heller G., Pekle K., Black P., Pecora A., Gillio A., Keman N., O'Reilly R. Immune reconstitution following bone marrow transplantation: comparison of recipients of T‐cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340–1350
   PubMed Web of Science ®Google Scholar
• Parkman R., Weinberg K. Immunological reconstitution following bone marrow transplantation. Immunological Reviews 1997; 157: 73–78
   PubMed Web of Science ®Google Scholar
• Ottinger H. D., Beelen D. W., Scheulen B., Schaefer U. W., Grosse‐Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775–2779
   PubMed Web of Science ®Google Scholar
• Storek J., Witherspoon R. P., Maloney D. G., Chauncey T. R., Storb R. Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 1997; 89: 3891–3893
   PubMed Web of Science ®Google Scholar
• Shenoy S., Mohanakumar T., Todd G., Westhoff W., Dunnigan K., Adkins D. R., Brown R. A., DiPersio J. F. Immune reconstitution following peripheral blood stem cell transplants. Bone Marrow Transplant 1999; 23: 335–349
   PubMed Web of Science ®Google Scholar
• Vacca A., Felli M. P., Farina A. R., Martinotti S., Maroder M., Screpanti I., Meco D., Pentrangeli E., Frati L., Gulino A. Glucocorticoid receptor‐mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP‐1 enhanced elements. J Exp Med 1992; 175: 637–646
   PubMed Web of Science ®Google Scholar
• Femandez‐Ruiz E., Rebollo A., Nieto M. A. IL‐2 protects T cells hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL‐2 and dexarnethasone in the induction of high‐affinity IL‐2 receptors. J Immunol 1989; 143: 4146–4151
   PubMed Web of Science ®Google Scholar
• Lanza L., Scudeletti M., Puppo F., Bosco O., Peirano L., Filaci G., Fecarotta E., Vidali G., Indiveri E. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 1996; 103: 482–490
   PubMed Web of Science ®Google Scholar
• Mackall C., Granger L., Sheard M., Cepeda R., Gress R. T‐cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic‐derived versus thymic‐independent progeny. Blood 1993; 82: 2585–2594
   PubMed Web of Science ®Google Scholar
• Mackall C., Fleisher T., Brown M., Andrich M., Chen C., Feuerstein I., Horowitz M., Magrath I., Shad A., Steinberg S., Wexler L., Grew R. Age, thymopoiesis, and CD4+ T‐lymphocyte regeneration after intensive chemotherapy. N Eng J Med 1995; 332: 143–149
   PubMed Web of Science ®Google Scholar
• Mackall C., Gress R. Pathways of T‐cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunological Reviews 1997; 157: 61–72
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Mordini N., Pitto A., Piaggio G., Podesta M., Benvenuto F., Van Lint M., Valbonesi M., Lercari G., Carlier P., Lamparelli T., Gualandi F., Occhini D., Bregante S., Figari O., Soracco M., Vassalo F., De Stefano G. Transplantation of HLA‐mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. Br J Haematol 1997; 98: 760–766
   PubMed Web of Science ®Google Scholar
• Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., Iacucci R., Zei T., Martelli M., Gambeluinghe C., Rossetti M., Caputo P., Latini P., Arestei C., Raymondi C., Reisner Y., Martelli M. Successful engraftment of T‐cell depleted “three loci” incompatible transplants in leukemia patients by addition of granulocyte colony‐stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948–3955
   PubMed Web of Science ®Google Scholar
• Rosillo M. C., Ortuño F., Moraleda J. M., Lozano M. L., Heras I., De Amiba F., Vicente V. Immune recovery after autologous or rhG‐CSF primed PBSC transplantation. Eur J Haematol 1996; 56: 301–307
   PubMed Web of Science ®Google Scholar
• Bensinger W., Weaver C. H., Appelbaum F. R., Rowley S., Demirer T., Sanders J., Storb R., Buckner C. D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony‐stimulating factor. Blood 1995; 85: 1655–1658
   PubMed Web of Science ®Google Scholar
• Schmitz N., Dreger P., Suttorp M., Rohwedder E. B., Haferlach X., Löeffler H., Hunter A. E., Russell N. H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony‐stimulating factor). Blood 1995; 85: 1666–1672
   PubMed Web of Science ®Google Scholar
• Korbling M., Huh Y. O., Durett A., Mirza N., Miller P., Engel H., Anderlini P., van Beslen K., Andreeff M., Przepiorka D., Deisseroth A. B., Champlin R. E. Allogeneic blood stem cell transplantation: peripheralization and yield of donor‐derived primitive hematopoietic progenitor cells (CD34+Thy‐1dim) and lymphoid subsets, and possible predictors of engraftment and graft‐versus‐host‐disease. Blood 1995; 86: 2842–2848
   PubMed Web of Science ®Google Scholar
• Bensinger W., Buckner M., Shanon‐Dorcy K., Rowley S., Appelbaum E., Benyunes M., Cliff R., Martin P., Demirer T., Storb R., Lee M., Schiller G. Transplantation of allogeneic CD34‐t peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88: 4132–4138
   PubMed Web of Science ®Google Scholar
• Schmitz N., Bacigalupo A., Hasenclever D., Nagler J., Gluckman E., Clark P., Varet B., Greinix H., Frickhofen N., Ringden O., Zander A., Apperley J., Gorin N., Borkett K., Schwab G., Goebel M., Russell N. H., Gratwohl A. Allogeneic bone marrow transplantation versus filgrastim‐mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: results of a randomized multicentre study. Bone Marrow Transplant 1998; 21: 995–1003
   PubMed Web of Science ®Google Scholar
• Korbling M., Mirze N., Przepiorka D., Anderlini P., Chan K., Champlin R. Clinical outcome of 112 patients following HLA‐identical allogeneic peripheral blood stem cell transplantation. Blood 1997; 10(Suppl. 1)224a
   Google Scholar
• Storek J., Gooley T., Siadak M., Bensinger W., Maloney D., Chauncey T., Flowers M., Sullivan K., Witherspoon R., Rowley S., Hansen J., Storb R., Appelbaum F. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft‐versus‐host disease. Blood 1997; 90: 4705–4709
   PubMed Web of Science ®Google Scholar
• Solano C., Martínez C., Brunet S., Tomas J. F., Urbano‐Ispizua A., Zuazu J., Ojeda E., Bargay J., Moraleda J. M., Bailen A., Sierra J., García‐Conde J., Rozman C. Chronic graft‐versus‐host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case‐control study. Bone Marrow Transplant 1998; 22: 1129–1135
   PubMed Web of Science ®Google Scholar
• Matsuda Y., Hara J., Osugi Y., Fujisaki H., Takai K., Ohta H., Nakanishi K., Tokimasa S., Miyoshi H., Tanaka‐Taya K., Yamanishi K., Okada S. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA‐mismatched donors. Bone Marrow Transplant 1998; 21: 355–360
   PubMed Web of Science ®Google Scholar
• Bomberger C., Singh‐Jairam M., Rodey G., Guerriero A., Yeager A. M., Fleming W. H., Holland H. K., Waller E. K. Lymphoid reconstitution after autologous PBSC transplantation with FACS‐sorted CD34+ hematopoietic progenitors. Blood 1998; 91: 2588–2600
   PubMed Web of Science ®Google Scholar
• Link H., Arseniev L., Ljungman P., Alessandrino E. P., Amadon S., Bandini G., Beguin Y., Brinch L., Brunet S., Chopra R., Cordonnier C., De Witte T., Fauser A., Ferrant A., García‐Conde J., Juliusson G., Kubel M., Manna A. T., Martinez‐Rubio A. M., Mundhenk P., Ordernann R., Ortega J. J., Potter M., Prentice H. G., Raimondi R., Remez K., Reusser P., Rovira M., Russell J., Selleslag D., Uderzo C., Zaucha J. M. Cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation: a survey of the infectious disease working party of the EBMT. Bone Marrow Transplant 1998; 21(Suppl. l)5139
   Google Scholar
• Urbano‐Ispizua A., Rozman C., Martínez C., Marín P., Briones J., Rovira M., Fkliz P., Viguria M. C., Merino A., Sierra J., Mazzara R., Carreras E., Montserrat E. Rapid engraftment without significant graft‐versus‐host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. Blood 1997; 89: 3967–3973
   PubMed Web of Science ®Google Scholar